Sequencing 1 1 0
We undertook a whole exome sequencing (WES) approach to identify the 1 1 1 The Genotype Tissue Expression (GTex) 48 were used to assess domain 1 3 0 architecture and tissue specific gene expression. Sanger sequencing was 1 3 1 performed to determine cosegregation of candidate genes in the study family 1 3 2 as well as detect further mutations in our consecutive 98 TAAD cohort. blocking lmod1b (5'-ATTTCCATTTCCTACCTTTTTGAGC-3') were injected 1 7 4
Variant Interpretation
into 1-2 cell embryos to knock down candidate genes and evaluate the 1 7 5 phenotype of morphants compared to un-injected wild-type control fish using 1 7 6 confocal microscopy at 3-4 days post fertilization (dpf). Fluorescent microscopy was employed to investigate MO injected fish processed with an 1 7 8
actin-filament phalloidin stain and Dextran dyes, highlighting the vasculature. To obtain an enhanced resolution at confocal microscopy, Tg(kdrl:GFP) 50 fish 1 8 0 were used to highlight the vasculature, in particular the aortic arches of MO The LMOD1 c.1631C>A, p.(P544H) allele found in the proline-rich region is 4 3 9
predicted to bind profilin, which is thought to be involved in actin dynamics, . The mutant residue is larger than the wild-type, internationally and it may be useful to add this small three-exon gene to future 4 9 3 TAAD panels.
9 4
Sequencing of other TAAD cohorts will determine a worldwide incidence. In . Upward lines indicate alleles found in three cohorts (red variants from the UK cohort, black from the USA and green from French co Downward lines indicate variants present on gnomAD, and the length indicates the number of times it has been reported from their databas Downward lines truncated from 20X. Table 1 . In-silico analysis of only the rare missense alleles detected in 98 UK, 800 USA and 403 French TAAD probands. The table includes columns for the cohort, mutation at nucleotide level, consequence on protein level (HGVS-Human Genome Variation Society nomenclature-NM_012134), Combined Annotation-Dependent Depletion (CADD) score, PhastCons score, In-silico predictions (Polyphen-2, GVGD, UMD-Predictor, SIFT and PROVEAN (+) -Damaging in two or more in-silico tools used (-) -Damaging in one or none of the in-silico tools used.), gnomAD allele frequency, cosegregation tested (N/A-No cosegregation performed). Rows highlighted in grey are predicted to be disease-causing mutations due to high CAAD scores (>20), PhastCons 100 score (>0.9) and damaging (+) upon in-silico predictions. 
